youtube_live
Q2 2027 – zárobky • o 5 d.
Zobraziť podrobnostichevron_right
RDY:NYSE
Dr Reddy's Laboratories Ltd
13,07 USD
arrow_upward
+1,32%(+0,17) 1 d.
13,07 USD
0,00% (0,00)
bedtimePo uzavretí
Zavreté: 16. 10., 16:00:07 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre RDY…
Otvoriť
13,00 USD
Vysoká
13,07 USD
Nízka
12,94 USD
Trh. kap.
10,81 mld.
Priem. obj.
3,19 mil.
Objem
2,79 mil.
Dividenda
0,64 %
Štvrťročná dividenda
0,02 USD
Prvý obchodný deň po vyplatení dividendy
10. 7. 2026
Pomer cena/zárobky
31,34
Max. za 52 týž.
15,67 USD
Min. za 52 týž.
11,36 USD
Výnosy na akciu
0,42 USD
Beta
0,30
Akcie v obehu
834,64 mil.
Počet zamestnancov
28 tis.
Otvoriť
13,00 USD
Vysoká
13,07 USD
Nízka
12,94 USD
Trh. kap.
10,81 mld.
Priem. obj.
3,19 mil.
Objem
2,79 mil.
Dividenda
0,64 %
Štvrťročná dividenda
0,02 USD
Prvý obchodný deň po vyplatení dividendy
10. 7. 2026
Pomer cena/zárobky
31,34
Max. za 52 týž.
15,67 USD
Min. za 52 týž.
11,36 USD
Výnosy na akciu
0,42 USD
Beta
0,30
Akcie v obehu
834,64 mil.
Počet zamestnancov
28 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Foreign Policy Journal
·
pred 16 minútami
Super Micro Computer (NASDAQ: SMCI) Signals Were Visible Before Its Stock 45% Rally
Yahoo Finance
·
pred 10 hodinami
Michael Burry Warns of a Stock Market ‘Supervolcano’
AOL.com
·
pred 7 hodinami
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
MarketWatch
·
pred 6 hodinami
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Informácie o subjekte Dr Reddy's Laboratories Ltd
Generálny riaditeľErez Israeli
Zamestnanci27,5 tis.
Dátum založenia1984
Hlavné sídloHajdarabád, Andhrapradéš, India
Odvetvie-
Webdrreddys.com